TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1)
According to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed in patients with stable ischemic heart disease prior to hospitalization. Significant impro...
Saved in:
Main Authors: | S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2)
by: S. N. Tolpygina, et al.
Published: (2015-09-01) -
HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER
by: S. N. Tolpygina, et al.
Published: (2015-09-01) -
The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
by: S. N. Tolpygina, et al.
Published: (2015-12-01) -
Enhanced risk stratification scale for predicting death and non-fatal cardiovascular events in patients of the PROGNOZ IBS registry
by: S. N. Tolpygina, et al.
Published: (2021-11-01) -
Prognostic value of calcific aortic stenosis in patients of the PROGNOZ IBS registry
by: S. N. Tolpygina, et al.
Published: (2022-02-01)